Network GBoDC. Global Burden of Disease Study 2019 (GBD 2019) (Institute for Health Metrics and Evaluation (IHME), 2020).
Finkelstein, E. A., Lau, E., Doble, B., Ong, B. & Koh, M. S. Economic burden of asthma in Singapore. BMJ Open Respir. Res. 8, e000654 (2021).
Article PubMed PubMed Central Google Scholar
Yang, X. et al. Medical resource utilization and the associated costs of asthma in China: a 1-year retrospective study. BMC Pulm. Med. 23, 463 (2023).
Article PubMed PubMed Central Google Scholar
Lee, E.-W., Kim, H.-S., Kim, W., Nam, J.-Y. & Park, J.-H. Socioeconomic burden of disease due to asthma in South Korea. Asia Pac. J. Public Health 32, 188–193 (2020).
Tay, T. R. et al. Comparison of the proportion and healthcare utilisation of adult patients with uncontrolled severe asthma versus non-severe asthma seen in a Southeast Asian hospital-based respiratory specialist clinic. Ann. Acad. Med. Singap. 46, 217–228 (2017).
Helen, K. R. et al. GINA 2019: a fundamental change in asthma management. Eur. Respir. J. 53, 1901046 (2019).
Suissa, S., Ernst, P., Benayoun, S., Baltzan, M. & Cai, B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N. Engl. J. Med. 343, 332–336.
Mäkelä, M. J., Backer, V., Hedegaard, M. & Larsson, K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir. Med. 107, 1481–1490 (2013).
Gamble, J., Stevenson, M., McClean, E. & Heaney, L. G. The prevalence of nonadherence in difficult asthma. Am. J. Respir. Crit. Care Med. 180, 817–822 (2009).
Williams, L. K. et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J. Allergy Clin. Immunol. 114, 1288–1293 (2004).
Article PubMed CAS Google Scholar
Harrison, B., Stephenson, P., Mohan, G. & Nasser, S. An ongoing confidential enquiry into asthma deaths in the Eastern Region of the UK, 2001-2003. Prim. Care Respir. J. 14, 303–313 (2005).
Article PubMed PubMed Central Google Scholar
Jansen, E. M. et al. Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers. J. Thorac. Dis. 13, 3846–3864 (2021).
Article PubMed PubMed Central Google Scholar
Dima, A. L. et al. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur. Respiratory J. 45, 994 (2015).
Chiu, K. C. et al. Patients’ beliefs and behaviors related to treatment adherence in patients with asthma requiring maintenance treatment in Asia. J. Asthma 51, 652–659 (2014).
Article PubMed PubMed Central CAS Google Scholar
Lam, S. S. W. et al. Development of a real-world database for asthma and COPD: The SingHealth-Duke-NUS-GSK COPD and Asthma Real-World Evidence (SDG-CARE) collaboration. BMC Med. Inform. Decis. Mak. 23, 4 (2023).
Article PubMed PubMed Central Google Scholar
World Health O. IntErnational Classification of Diseases—Ninth REvision (ICD-9) = Classification Internationale DES_x000D_Maladies - Neuvième Révision (CIM-9). Wkly. Epidemiol. Rec. = Relevé. Epidémiologique Hebd. 63, 343–344 (1988).
World Health O. ICD-10: International Statistical Classification of Diseases and Related Health Problems: Tenth Revision. 2nd edn (World Health Organization, 2004).
Asthma GIf. Global Strategy for Asthma Management and Prevention (2015) Available from https://ginasthma.org/wp-content/uploads/2023/04/GINA-2015-main-report-final-WMSA.pdf.
Williams, L. K. et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J. Allergy Clin. Immunol. 128, 1185–91.e2 (2011).
Article PubMed PubMed Central Google Scholar
Elkout, H., Helms, P. J., Simpson, C. R. & McLay, J. S. Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children. PLoS ONE 7, e39130 (2012).
Article PubMed PubMed Central CAS Google Scholar
Nwaru, B. I. et al. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur. Respir. J. 55, 1901872 (2020).
Article PubMed PubMed Central CAS Google Scholar
R Core Team R. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2013).
National Population and Talent Division, Strategy Group, Prime Minister’s Office, Singapore. Population in brief 2019. https://www.population.gov.sg/files/media-centre/publications/population-in-brief-2019.pdf (2019).
Bateman, E. D. et al. As-needed Budesonide–Formoterol versus maintenance Budesonide in mild asthma. N. Engl. J. Med. 378, 1877–1887 (2018).
Article PubMed CAS Google Scholar
O’Byrne, P. M. et al. Inhaled combined Budesonide–Formoterol as needed in mild asthma. N. Engl. J. Med. 378, 1865–1876 (2018).
Hardy, J. et al. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet 394, 919–928 (2019).
Article PubMed CAS Google Scholar
Beasley, R. et al. Controlled trial of Budesonide–Formoterol as needed for mild asthma. N. Engl. J. Med. 380, 2020–2030 (2019).
Lim, D. et al. Trends in sales of inhaled corticosteroids and asthma outcomes in Singapore. Thorax 61, 362 (2006).
Article PubMed PubMed Central CAS Google Scholar
Sistani, F., Reed, R. M., Shah, C. H. & Zafari, Z. Trends in Medicaid spending on inhalers in the United States, 2012-2018. J. Manag. Care Spec. Pharm. 27, 1744–1749 (2021).
Chloe, I. B., Sejal, S., Johanna, F., Debbie, J. & Jennifer, K. Q. Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016. Eur. Respir. J. 53, 1802130 (2019).
McCabe, H. et al. Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications. Expert Rev. Respir. Med. 13, 679–689 (2019).
Article PubMed CAS Google Scholar
Noble, J. et al. Patterns of asthma medication use and hospital discharges in New Zealand. J. Allergy Clin. Immunology: Glob. 3, 100258 (2024).
Subhabrata, M., Andrew, F. & Mohit, B. An inverse relationship between asthma prevalence and medication dispensation trend: a 12-year spatial analysis of electronic health record data in Alberta, Canada. ERJ Open Res. 9, 00489–02022 (2023).
Zghebi, S. S., Mohamed, M. O., Mamas, M. A. & Kontopantelis, E. Temporal trends of hospitalizations, comorbidity burden and in-hospital outcomes in patients admitted with asthma in the United States: Population-based study. PLoS ONE 17, e0276731 (2022).
Article PubMed PubMed Central CAS Google Scholar
Lim, L. H. M., Chen, W., Amegadzie, J. E. & Lim, H. F. The increasing burden of asthma acute care in Singapore: an update on 15-year population-level evidence. BMC Pulm. Med. 23, 502 (2023).
Article PubMed PubMed Central Google Scholar
Martinez, F. D. Asthma in the Time of COVID-19. Am. J. Respir. Crit. Care Med. 203, 785–786 (2021).
Article PubMed PubMed Central CAS Google Scholar
Florence, T. et al. Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK). Thorax 78, 752 (2023).
Vervloet, M. et al. Understanding relationships between asthma medication use and outcomes in a SABINA primary care database study. NPJ Prim. Care Respir. Med. 32, 43 (2022).
Article PubMed PubMed Central Google Scholar
Michaud, A., Hernandez, P., Penz, E. D. & Walker, B. L. Beware SABA overuse: a message from the global SABINA program. Curr. Treat. Options Allergy 10, 15–27 (2023).
留言 (0)